-
Pediatric Blood & Cancer Mar 2022
Topics: Child; Hematology; Humans; Job Description; Medical Oncology; Oncologists
PubMed: 34989459
DOI: 10.1002/pbc.29524 -
Annals of Surgical Oncology Jul 2020Advancements in clinical practice usually require level one evidence from clinical trials that directly compare new approaches to standard of care. While clinical trials... (Review)
Review
Advancements in clinical practice usually require level one evidence from clinical trials that directly compare new approaches to standard of care. While clinical trials have provided data to guide advances in practices across surgical oncology, all too often accrual to clinical trials is slower than anticipated, and once results are presented and published, adoption in clinical practice is slow. Why and how can surgeons be successfully involved with clinical trials? An expert panel discusses the basic infrastructure of clinical trials, investigator-initiated trials, the National Clinical Trials Network, and opportunities for surgeon involvement. Two national clinical trials, NSABP B-51/RTOG 1304 and PROSPECT N1048, are discussed to highlight the role of the surgical oncologist.
Topics: Clinical Trials as Topic; Humans; Oncologists
PubMed: 32318946
DOI: 10.1245/s10434-020-08472-z -
Journal of Clinical Oncology : Official... Jun 2022
Topics: Humans; Oncologists; Physician-Patient Relations
PubMed: 35471932
DOI: 10.1200/JCO.22.00158 -
Der Pathologe Sep 2017
Review
Topics: Autopsy; Hematology; Humans; Oncologists
PubMed: 28656361
DOI: 10.1007/s00292-017-0318-5 -
Medical Oncology (Northwood, London,... Sep 2022Since the first definition by Hellman and Weichselbaum in 1995, the concept of OligoMetastatic Disease (OMD) is a growing oncology field. It was hypothesized that OMD is... (Review)
Review
Since the first definition by Hellman and Weichselbaum in 1995, the concept of OligoMetastatic Disease (OMD) is a growing oncology field. It was hypothesized that OMD is a clinical temporal window between localized primary tumor and widespread metastases deserving of potentially curative treatment. In real-world clinical practice, OMD is a "spectrum of disease" that includes a highly heterogeneous population of patients with different prognosis. Metastasis directed therapy with local ablative treatment have proved to be a valid alternative to surgical approach. Stereotactic body radiation therapy demonstrated high local control rate and increased survival outcomes in this setting with a low rate of toxicity. However, there is a lack of consensus regarding many clinical, therapeutic, and prognostic aspects of this disease entity. In this review, we try to summarize the major critical features that could drive radiation oncologists toward a better selection of patients, treatments, and study endpoints. With the help of a set of practical questions, we aim to integrate the literature discussion.
Topics: Consensus; Humans; Neoplasms; Prognosis; Radiation Oncologists; Radiosurgery
PubMed: 36071292
DOI: 10.1007/s12032-022-01788-8 -
Journal of Cancer Research and... 2022The diagnosis of malignancy, particularly brain tumors, in pregnancy is uncommon but poses a complex dilemma for the management of both the patient and her fetus, as the... (Review)
Review
The diagnosis of malignancy, particularly brain tumors, in pregnancy is uncommon but poses a complex dilemma for the management of both the patient and her fetus, as the interplay of disease with the physiological state of pregnancy affects both outcomes. The routine evaluations (symptomatology, imaging, and hormonal assessments) and treatments (surgery, radiation therapy, and chemotherapy) that are commonplace in brain tumor management may need to be omitted or modified keeping in mind the risk to offspring. Multidisciplinary care and extensive prenatal and perinatal counseling and monitoring are essential. In this review, we discuss the available data addressing these issues and factors which may affect considerations of therapeutic abortions, changes in surgical or medical practices, and outcomes thereof.
Topics: Brain Neoplasms; Counseling; Female; Humans; Oncologists; Pregnancy
PubMed: 35381756
DOI: 10.4103/jcrt.JCRT_1343_20 -
JCO Oncology Practice Sep 2023
Topics: Humans; Curriculum; Oncologists
PubMed: 37379500
DOI: 10.1200/OP.23.00165 -
Nursing Administration QuarterlyA 50% estimated increase in new cancer cases over the next few decades will significantly challenge health care systems already strained by a shortage of oncology...
A 50% estimated increase in new cancer cases over the next few decades will significantly challenge health care systems already strained by a shortage of oncology providers. Radiation oncology (RO), 1 of 3 three primary pillars of oncology care, treats half of all new cancer cases. Workforce shortages, reimbursement changes, delays in patient treatment, and the lack of follow-up care all continue to increase pressure on RO centers to boost efficiency, improve patient and staff retention, and strive for service satisfaction. Nurse practitioners (NPs) can bring greater capacity, expertise, and profitability to RO, especially in light of the fact that demand is predicted to outstrip supply by as much as 10 times. It is critical, however, that NPs receive specialized training in RO's clinical, technological, and operational processes before assuming patient-facing roles.
Topics: Humans; Radiation Oncologists; Delivery of Health Care; Radiation Oncology; Workforce; Neoplasms
PubMed: 37643229
DOI: 10.1097/NAQ.0000000000000599 -
Critical Reviews in Oncology/hematology Oct 2020This manuscript represents a collaboration from an international group of quality and safety expert radiation oncologists. It is a position/review paper with the... (Review)
Review
This manuscript represents a collaboration from an international group of quality and safety expert radiation oncologists. It is a position/review paper with the specific aim of defining the role of the radiation oncologist in quality and safety management. This manuscript is unique in that we recommend specific quality assurance/control tasks and correlated quality and indicators and safety measures that are the responsibility of the radiation oncologist. The article addresses the role of the radiation oncologist in quality and safety from a strong perspective of multidisciplinarity and teamwork. Our manuscript is "cross-cutting" and applicable to radiation oncologist in any practice setting (i.e. low middle-income countries).
Topics: Benchmarking; Humans; Radiation Oncologists
PubMed: 32769020
DOI: 10.1016/j.critrevonc.2020.103045 -
International Journal of Radiation... Oct 2017Consideration of clinical research ethics in radiation oncology is underexplored relative to other areas of oncology. A number of ethical challenges related to informed... (Review)
Review
Consideration of clinical research ethics in radiation oncology is underexplored relative to other areas of oncology. A number of ethical challenges related to informed consent, randomization, conflicts of interest, and scientific validity and social value are shared with other areas of medicine, although their exact inflections are specific to radiation oncology. In addition, there are unique concerns in radiation oncology arising from the rapid evolution and uneven distribution of radiation technologies; the greater unfamiliarity of the general public and research oversight committees in regard to radiation oncology clinical practice; and the high complexity of managing most radiation oncology research, much of which is carried out in high-acuity multidisciplinary oncologic settings. To produce the best research, adherence to the highest ethical standards should be pursued as an integral component of all radiation oncology research.
Topics: Conflict of Interest; Ethics, Research; Humans; Informed Consent; Oncologists; Radiation Oncology; Reproducibility of Results; Social Values
PubMed: 28871967
DOI: 10.1016/j.ijrobp.2017.06.001